 IRVINE, Calif.--BUSINESS WIRE--Axonics, Inc. Nasdaq: AXNX, a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the second quarter ended June 30, 2021. This quarters record revenue result reflects the growing demand for our best-in-class incontinence solutions, said Raymond W. Cohen, chief executive officer of Axonics. Clinical outcomes and satisfaction with our 